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Serological, sequence, and in vitro host range analyses of feline parvovirus (FPV) isolates in Vietnam and Taiwan revealed
that more than 80% of the isolates were of the canine parvovirus (CPV) type, rather than feline panleukopenia virus (FPLV).
Although parvovirus isolates from three Vietnamese leopard cats were genetically related to CPV type 2a or 2b, they had a
natural mutation of VP2 residue 300 Gly to an Asp, resulting in remarkable changes in their antigenic properties. These
results indicated the possibility that CPV-2a/2b-type viruses can spread in cats more efficiently than conventional FPLV under
natural conditions and that CPV-2a/2b viruses are further evolving in cats. © 2000 Academic PressIntroduction. The appearance of new viruses with
pathogenic potential is a constant threat to humans and
animals. The diseases caused by feline parvovirus (FPV)
were known to occur only in cats (feline panleukopenia
virus, FPLV) or raccoons until the mid-1940s, when a
similar disease with a high mortality was observed in
mink (1). Although the mink agent, named mink enteritis
virus (MEV), was indistinguishable from FPLV by conven-
tional methods, a panel of monoclonal antibodies (MAbs)
classified FPLV and MEV isolates into three antigenic
types, FPLV and MEV type 1 (MEV-1), MEV type 2 (MEV-2)
and MEV type 3 (1). In the late 1970s, another parvovirus
emerged in dogs. The new virus, canine parvovirus (CPV)
[designated CPV type 2 (CPV-2) to distinguish it from an
unrelated parvovirus, minute virus of canines], rapidly
spread worldwide and initially killed thousands of unpro-
tected dogs (2). Since CPV-2 was shown to be antigeni-
cally and genetically very close to FPLV (3), FPLV and
CPV are classified as host-range variants of FPV.
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13At present, the most widely accepted hypothesis on
the ancestor of CPV-2 is the emergence from a variant of
FPLV or of a closely related virus infecting another car-
nivore, such as mink or fox (4). Since the emergence of
CPV-2, two new antigenic types of CPV, designated CPV
types 2a and 2b (CPV-2a and CPV-2b), arose consecu-
tively and the new virus types almost completely re-
placed CPV-2-type viruses worldwide (5). These obser-
vations set FPVs as a significant model for natural viral
evolution. CPV strains replicate in both canine and feline
cells in vitro, whereas FPLV strains efficiently replicate
only in feline cells (6–8). In contrast to the in vitro char-
acteristics, CPV-2 viruses do not have the in vivo feline
host range (8, 9). Recently, we and others reported the
isolation of CPV-2a- or CPV-2b-like viruses from domes-
tic cats in Japan and the United States (9–11), suggesting
that CPV-2a and CPV-2b gained a feline host range, while
the proportion of CPV-like viruses from domestic cats
was at most 10% in these countries.
In the present study, we examined 18 recent parvovi-
rus isolates from domestic and leopard cats in Vietnam
and Taiwan. Since few animals are vaccinated against
FPV infection, especially in Vietnam, the isolates might
show the natural evolutionary patterns of FPV subfami-
lies. Elucidation of how FPVs evolve may help to prevent
a possible outbreak of a new type of FPV.
Results. Growth properties of the isolates in feline
FL74 and canine CL-1 cells. Although the virus stocks of
all the isolates were shown to have more than 105 TCID50
(50% tissue culture infective doses)/ml in FL74 cells,
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CPV-2b, respectively. No. 402 (FPLV), Cp49 (CPV-2), CPV 97-003 (CPV-2a), and




CPV-2, CPV-2a, and CPV-2b, respectively. The titers are shown as
TCID /ml.
14 RAPID COMMUNICATIONFPLV and MEV reference strains as well as one domestic
feline isolate V211 did not replicate in the CL-1 cells (Fig.
1). In contrast, like CPV reference strains, two Taiwanese
and most of the Vietnamese isolates had more than 103
TCID50/ml in the canine cells, while the titers of V208,
eopard cat parvovirus (LCPV)-203, LCPV-139, and LCPV-
40 in CL-1 cells were relatively low. These results sug-
est that most of the recent Asian feline isolates have the
n vitro canine host range.
Reactivity of MAbs against FPVs by the Hemaggluti-
ation-Inhibition (HI) Assay. As shown in Table 1, the HI
nalyses with the panel of 13 MAbs revealed that most of
he parvovirus isolates from domestic and leopard cats
n Vietnam and Taiwan were of either the CPV-2a or the
PV-2b type, while only three isolates, V142, V208, and
211, were shown to be of the FPLV type. Interestingly,
hree Vietnamese wild feline isolates (LCPV-V139, LCPV-
140, and LCPV-V203) were demonstrated to be new
ntigenic types, while the reactivity against MAbs P2-215
nd A4E3 indicated that the three viruses were of the
PV type. Thus, we designate the new antigenic types of
PV—which do not react with MAbs A3B10, B6D5, C1D1,
D9, 3G5, and 4G1—as CPV-2c viruses. In addition, the








B4A2 2D9 3G5 4G1
Antigenic
type
128 1024 NT 16 NT NT NT CPV-2a
64 1024 NT 32 NT NT NT CPV-2a
,4 ,4 NT 16 NT NT NT FPLV
128 1024 NT 16 NT NT NT CPV-2a
,4 ,4 NT 32 NT NT NT FPLV
,4 ,4 NT 32 NT NT NT FPLV
128 1024 NT 16 NT NT NT CPV-2a
128 ,4 ,4 32 ,10 ,100 ,10 CPV-2c
128 ,4 ,4 32 ,10 ,100 ,10 CPV-2c
64 ,4 NT ,4 ,10 ,100 ,10 CPV-2c
64 1024 NT ,4 NT NT NT CPV-2b
128 512 NT ,4 80 800 40 CPV-2b
,4 ,4 NT 32 NT NT NT
,4 ,4 NT 32 NT NT NT
,4 ,4 NT 32 NT NT NT Reference
64 ,4 ,4 16 640 8000 2560 strains
128 512 128 16 160 1000 320
64 512 128 ,4 160 2000 320





used as reference strains of FPLV, MEV-1, MEV-2, CPV-2, CPV-2a, andTABLE 1













Taiwan 9 12800 NT NT NT ,1,000 8
LCPV-T1 12800 NT NT NT ,1,000 8
V142 12800 NT NT NT 128,000 1024
V154 12800 NT NT NT ,1,000 8
V208 12800 NT NT NT 128,000 1024
V211 12800 NT NT NT 128,000 1024
V220 12800 NT NT NT ,1,000 8
LCPV-V139 ,100 ,4 ,4 ,4 ,1,000 ,4
LCPV-V140 ,100 ,4 ,4 ,4 ,1,000 ,4
LCPV-V203 ,100 ,4 NT NT ,1,000 ,4
LCPV-V204 12800 NT NT NT ,1,000 4
LCPV-V205 12800 256 NT NT ,1,000 4
FPLV 12800 NT NT NT 128,000 2048
MEV-1 12800 2048 NT 64 256,000 2048
MEV-2 200 512 NT ,4 256,000 4
CPV-2 12800 4096 ,4 16 ,1,000 2048
CPV-2a 12800 512 ,4 ,4 ,1,000 8
CPV-2b 12800 512 ,4 ,4 ,1,000 8
Specificity FPL FPL FPL FPLV FPLV FPLV C
MEV-1 MEV-1 MEV-1 MEV-1 MEV-1 MEV-1 C




Note. NT: not tested. TU-1, Abashiri, M-1, CPV-b, CPV-31, and CPV-39 were
50FIG. 1. Comparison of the titers of FPV isolates in feline FL74 and
anine CL-1 cells. As reference FPLV isolates, Japanese TU-1 and FPLV
o402 isolates were used. MEV M-1 isolate was used as an MEV
eference strain. Cp49, CPV97-003, and CPV97-008 were used asCPV 97-008 (CPV-2b) were also used as reference isolates and similar
Gly
15RAPID COMMUNICATIONreactivity against MAb B4A2 suggested that LCPV-203
was antigenically related to CPV-2b.
Sequence Analyses of the VP2 Capsid Gene. The full
VP2 nucleotide sequences of the isolates were deter-
mined and phylogenetically informative amino acid se-
quences were summarized. As shown in Table 2, most of
the isolates had the same VP2 amino acid sequences as
conventional CPV-2a or CPV-2b, in spite of their isolation
from cats, while only two isolates, V208 and V211, had the
exact FPLV VP2 amino acid sequences. Interestingly,
V142, which could replicate efficiently in canine cells
(Fig. 1) and was antigenically classified as FPLV-type
virus (Table 1), was shown to have almost the same VP2
amino acid sequences as conventional FPLV but pos-
sess one natural CPV-specific Asp-Asn substitution at
amino acid residue 323. On the other hand, the new
antigenic CPV-2c-type viruses, LCPV-V139, LCPV-V140,
and LCPV-V203, were genetically similar to CPV-2a/2b-
type viruses rather than to FPLV or CPV-2 and had a
natural mutation of VP2 residue 300 Gly to Asp in com-
mon, which might lead to the remarkable changes in
their antigenic properties. In addition, the amino acid
sequences of the three isolates at residue 426, which
determine the difference between CPV-2a/2b-type vi-
ruses, revealed that LCPV-V203 had CPV-2b-specific
Asp, while LCPV-V139 and LCPV-V140 had CPV-2a-spe-
cific Asn. Therefore, we designate LCPV-V203, LCPV-
T
Phylogenetically Informative Am
Isolates 80 87 93 103 232 297
Taiwan 9 Arg Leu Asn Ala Ile Ala
LCPV-T1 Arg Leu Asn Ala Ile Ala
V120 Arg Leu Asn Ala Ile Ala
V123 Arg Leu Asn Ala Ile Ala
V129 Arg Leu Asn Ala Ile Ala
V142 Lys Met Lys Val Val Ser
V154 Arg Leu Asn Ala Ile Ala
V208 Lys Met Lys Val Val Ser
V209 Arg Leu Asn Ala Ile Ala
V211 Lys Met Lys Val Val Ser
V217 Arg Leu Asn Ala Ile Ala
V220 Arg Leu Asn Ala Ile Ala
LCPV-V139 Arg Leu Asn Ala Ile Ala
LCPV-V140 Arg Leu Asn Ala Ile Ala
LCPV-V203 Arg Leu Asn Ala Ile Ala
LCPV-V204 Arg Leu Asn Ala Ile Ala
LCPV-V205 Arg Leu Asn Ala Ile Ala
FPLV/MEV-1 Lys Met Lys Val Val Ser
MEV-2/BFPV Lys Met Lys Val Val Ser
CPV-2 Arg Met Asn Ala Ile Ser
CPV-2a Arg Leu Asn Ala Ile Ser/Ala
CPV-2b Arg Leu Asn Ala Ile Ser/AlaV139, and LCPV-V140 as CPV-2c(b) and CPV-2c(a), re-
spectively.Phylogenetic Relationships of the Parvovirus Isolates
Based on the VP2 Nucleotide Sequences. To examine
the phylogenetic relationships of the recent Asian iso-
lates with representative FPLV, MEV, and CPV isolates,
phylogenetic analyses based on the full VP2 nucleotide
sequences were performed. As shown in Fig. 2A, the
phylogenetic tree consisted of three major groups, FPLV/
MEV-1/MEV-2, CPV-2, and CPV-2a/2b/2c. Although the
three Vietnamese FPLV-type isolates, V142, V208, and
V211, formed a small cluster with the other MEV-type
viruses, most of the Vietnamese and Taiwanese isolates
from cats formed one major cluster with the other CPV-
2a/2b-type isolates from dogs. Two CPV-2c(a)-type iso-
lates, LCPV-V139 and LCPV-V140, formed a small cluster
with the Vietnamese CPV-2a-type isolates, while the
CPV-2c(b)-type isolate, LCPV-V203, formed a group with
the Vietnamese CPV-2b-type viruses. The reasons that
CPV-2c(a)- or CPV-2c(b)- and Vietnamese CPV-2a- or
CPV-2b-type isolates form small clusters can be ex-
plained by the fact that they have a natural mutation at
nucleotide (nt) 537 from T to C or at nt 1659 from T to C
in common (Fig. 2B). These observations suggest the
possibility that the CPV-2c(a)- and CPV-2c(b)-type viruses
emerged from CPV-2a- and CPV-2b-type viruses, respec-
tively.
Discussion. In the present study, we examined 18
recent parvovirus isolates from domestic and leopard
id Sequences in the VP2 Gene
305 323 426 555 564 568 FPV-type
Tyr Asn Asn Val Ser Gly CPV-2a
Tyr Asn Asn Val Ser Gly CPV-2a
Tyr Asn Asn Val Ser Gly CPV-2a
Tyr Asn Asp Val Ser Gly CPV-2b
Tyr Asn Asn Val Ser Gly CPV-2a
Asp Asn Asn Val Asn Ala FPLV
Tyr Asn Asn Val Ser Gly CPV-2a
Asp Asp Asn Val Asn Ala FPLV
Tyr Asn Asp Val Ser Gly CPV-2b
Asp Asp Asn Val Asn Ala FPLV
Tyr Asn Asp Val Ser Gly CPV-2b
Tyr Asn Asn Val Ser Gly CPV-2a
Tyr Asn Asn Val Ser Gly CPV-2c(a)
Tyr Asn Asn Val Ser Gly CPV-2c(a)
Tyr Asn Asp Val Ser Gly CPV-2c(b)
Tyr Asn Asp Val Ser Gly CPV-2b
Tyr Asn Asp Val Ser Gly CPV-2b
Asp Asp Asn Val Asn Ala
Asp Asp Asn Val Asn Ala
Asp Asn Asn Val Ser Gly Reference
Tyr Asn Asn Ile Ser Gly strains























Glycats in Vietnam and Taiwan and demonstrated that 15 of
18 isolates are essentially identical to CPV isolates from
16 RAPID COMMUNICATIONFIG. 2. (A) Phylogenetic analysis of the complete VP2 nucleotide sequences of FPV isolates. The tree was constructed by the NJ (boot-strap)
program. DC, domestic cat; LC, leopard cat; DD, domestic dog; MK, mink; BF, blue fox. JPN, Japan; TWN, Taiwan; CHN, China; VTN, Vietnam; FNL,
Finland. (B) Phylogenetically informative nucleotide sequences in the VP2 gene. Phylogenetically informative nucleotide sequences, which all the
isolates classified as FPLV, MEV-1, FPLV (Vietnam), MEV-2, CPV-2, CPV-2a (United States), CPV-2a (Vietnam), CPV-2a (Taiwan), CPV-2c(a) (Vietnam),
















































17RAPID COMMUNICATIONdogs. Additionally, we reported the emergence of new
antigenic types of CPVs in cats.
There is a long-standing controversy over the question
of the origin of CPV-2, and the most widely accepted
hypothesis is that the virus arose from FPLV of domestic
cats or from FPV retained by closely related wildlife
animals (4). As shown in Fig. 1 and Table 2, although
V142 strain is antigenically classified as FPLV or MEV-1,
the isolate has a mutation of VP2 residue 323 Asp to
CPV-specific Asn, and this mutation may be ascribed to
its relatively high titers in a canine cell line. This obser-
vation confirms previous reports that amino acid resi-
dues at 93, 103, and 323 in VP2 protein determine canine
host range (12). These observations suggest the possi-
bility that FPLV can gain a canine host range by natural
mutation and support the hypothesis of the emergence of
CPV-2 from FPLV, although the phylogenetic analysis
indicates that V142 is unlikely to be a direct ancestor of
CPV-2 (Fig. 2). In addition, since the two very similar
viruses, FPLV and CPV-2a/2b, are circulating in cats at
the same time, it remains possible that this single amino
acid substitution has occurred by recombination be-
tween CPV and FPLV in vivo.
Parrish et al. (1) reported the antigenic differences
etween FPLV/MEV-1 and MEV-2, which resulted from a
utation of VP2 amino acid residue 300 Ala to Val.
imilarly, remarkable antigenic changes of the new-type
PVs were shown to be the result of a natural mutation
f VP2 residue 300 Gly to Asp (Tables 1 and 2). CPV-2c-
ype viruses were isolated only from leopard cats (Table
) and CPV-2a- and CPV-2b-type viruses were likely to
volve to CPV-2c(a)- and CPV-2c(b)-type viruses, respec-
ively (Figs. 2A and 2B). Therefore, it is probable that the
utation at the residue 300 Gly to Asp is ascribed to the
daptation of CPV-2a/2b-type viruses to leopard cats.
nterestingly, the same mutation was previously reported
n a mutant of CPV derived by 102 passages in primary
og kidney cells and 10 passages in NLFK cells, which
as antigenic properties and in vitro host range that are
ifferent from those of its parental strain (13). Moreover,
study using a CPV mutant containing the residue 300
sp mutation clearly demonstrated that the mutation
tabilizes the capsid (14). Therefore, it is possible that
he natural mutation at residue 300 found in LCPVs
esults in greater stability and has some advantages
ver conventional feline parvoviruses under natural con-
itions.
Although we and others previously reported on infec-
ion with CPV-like viruses in domestic cats in Japan and
he United States, the proportions of CPV-like viruses
rom cats were not high in these countries (9–11). How-
ver, as shown in Table 2, more than 80% of the FPV
solates from cats in Vietnam and Taiwan were essen-
ially identical to the CPVs from dogs. Recently, Steinel et
l. (15) reported the detection of CPV-2a/2b-related se-
uences from African large cats, suggesting that CPV-a/2b-type viruses are spreading in cat populations
orldwide. At present, the precise mechanism of the
redominance of CPV-2a/2b-type viruses in cats in these
ountries remains obscure. However, since FPVs are
ikely to spread freely and rapidly in the environment
here few cats and dogs are vaccinated against FPV, it
s indicated that CPV-2a/2b-type viruses have more ad-
antages over conventional FPLV in cats under natural
onditions. Therefore, it is possible that CPV-2a/2b-type
iruses will replace FPLV-type viruses in domestic cats in
he future, even in developed countries where FPV vac-
ines are commonly used.
As we reported previously, all the parvovirus isolates
n this study were isolated from the peripheral blood
ononuclear cells (PBMCs) of cats with high virus-neu-
ralizing antibodies against FPV and most of the cats
howed no clinical sign (16, 17), suggesting the possibil-
ity that the CPV-type viruses have lower virulence in the
infected cats and can infect cats persistently. Our pre-
liminary in vivo experiments using two Vietnamese CPV-
2a- and CPV-2c-type isolates from cats clearly demon-
strated that the CPV-2a-type viruses were less virulent
than FPLV in domestic cats, whereas CPV-2c virus
showed intermediate virulence in cats (18). In terms of
viral evolution, it is notable that CPV-2a/2b-type viruses
have comparatively lower virulence in spite of their pre-
dominance in cat population under natural conditions
(18, 19), since CPV-type viruses could act as a natural
vaccine against virulent FPLV-type viruses in cats. On the
other hand, in addition to the relatively high virulence of
CPV-2c, we found that the virus neutralizing antibody
titers in the cats experimentally infected with FPLV were
much lower against CPV-2c than against FPLV (160:2560
[n 5 2, 4 weeks after infection]) (18), suggesting that
CPV-2c-type viruses have some advantages over con-
ventional FPLV in cats vaccinated with a commercial
FPLV vaccine. Therefore, it will be necessary to monitor
the spread of CPV-2c-type viruses to prevent a possible
outbreak of the new-type viruses.
Materials and Methods. Viruses and cell culture. One
Taiwanese strain (Taiwan 9) and 10 Vietnamese strains
(V120, V123, V129, V142, V154, V204, V209, V211, V217,
and V220) were isolated from the PBMCs of domestic
cats in Taipei and Hanoi, respectively, as described pre-
viously (17). One FPV-like agent from a leopard cat (Felis
bengalensis) in Taiwan, designated as LCPV T1 strain,
and five isolates from Vietnamese leopard cats, LCPV-
V139, LCPV-V140, LCPV-V203, LCPV-V204, and LCPV-
V205, were reported previously (16). FPLV TU-1 (10), FPLV
No402 (isolated from a domestic cat in Japan in 1998),
MEV Abashiri (MEV-1, GenBank D00765), MEV M-1
(MEV-2, isolated from a mink in China in 1989), CPV-2
Cp49 (10) (GenBank D26081), CPV-b (CPV-2, GenBank
M38345), CPV-31 (CPV-2a, GenBank M24000), CPV 97-



















18 RAPID COMMUNICATION97-008 (CPV-2b, isolated from a dog in Japan in 1997),
and CPV-2b CPV-39 (GenBank M74849) strains were
used as reference strains. Sequences of the previously
published isolates were obtained from GenBank and the
accession numbers were Obihiro (AB000056, FPLV), TU4
(AB000068, FPLV), TU8 (AB000070, FPLV), FPV-b CU4
(M24004, FPLV), Som1 (AB000059, FPLV), Som4
(AB000061, FPLV), Philips Roxane (M24002, FPLV), FPV-
377 (U22188, FPLV), Abashiri (D00765, MEV-1), MEV-e
(U22191, MEV-1), MEV-d Johnson (M24001, MEV-2),
BFPV-1 (U22185, MEV-2/3), CPV-d (M23255, CPV-2),
RD-80 (U22192, CPV-2), CPV-133 (M74852), and FPV-314
(M78585, CPV-2a). Crandell feline kidney (CRFK) cells
(ATCC No. CCL94) were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% heat-inactivated
fetal calf serum (FCS) and antibiotics. Feline and canine
T-lymphoblastoid cell lines, FL74 and CL-1 cells, respec-
tively, were maintained in RPMI 1640 growth medium
supplemented with 10% FCS and antibiotics (20, 21).
Titration of Parvovirus Isolates in Feline and Canine
Cell Lines. To estimate the growth properties of FPVs in
eline and canine cells, parvovirus isolates with less than
hree passages in feline cells were titrated in both FL74
nd CL-1 cells. The virus infection was judged by FPV-
nduced cytopathic effects in the infected cells as re-
orted previously (7, 22). The TCID50 were calculated by
he method of Behrens–Ka¨rber as reported previously
20).
HI Assay and Virus Antigenic Analysis. Antigenic anal-
sis was performed by the HI assay with the panel of 13
Abs, as described previously (10). HI titers were deter-
ined as the inverse of the highest antibody dilution
ompletely inhibiting viral HA. MAbs A3B10 (MAb8),
6D5 (MAbF), B2F12 (MAbG), B2G11 (MAbH), B4E1
MAbD), A4E3 (MAb14), C1D1 (1D1), C7D6 (7D6), and
4A2 (MAbI) were previously reported elsewhere (23). P1-
15, 2D9, 3G5, and 4G1 were reported previously (10, 24).
Sequencing and Phylogenetic Analysis of the VP2
ene of the Isolates. For nucleotide sequencing analy-
is, six synthetic oligonucleotide primers were used. The







To amplify the VP2 gene by PCR, a primer pair, 51 and R3,
was used and the amplified fragments were directly
subjected to sequence analysis. Sequencing reactions
were performed by the dideoxynucleotide chain termina-
tion method with the six primers using Big Dye Termina-
tor cycle sequencing kit (Applied Biosystems [ABI], Fos-ter City, CA) according to the manufacturer’s instruc-
tions. The samples were resolved on an automated DNA
sequencer (ABI Model 377A). The phylogenetic analysis
was carried out using NJ (boot-strap) program of
GENETIC-MAC ver. 9.0 (Software Development Co., Tokyo,
Japan).
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